文献速递冠心病外科瓣膜外科

冠状动脉旁路移植术合并中度主动脉瓣狭窄的最佳管理策略

Optimal Management for Moderate Aortic Stenosis at Time of Coronary Artery Bypass Grafting.
PubMed 文献 · Ann Thorac Surg · 2026-05-14

该研究基于STS成人心脏外科数据库,比较65岁及以上中度主动脉瓣狭窄患者行单纯CABG与CABG+SAVR的结局。单纯CABG组手术死亡率和术后并发症更低,中期全因死亡率相似,但心衰再入院和主动脉瓣干预风险更高,8年AV干预率分别为25.9%与2.4%。

要点

  • 中度AS患者CABG时推迟SAVR可降低手术风险且不增加中期死亡率。
  • 单纯CABG组中期心衰再入院和主动脉瓣干预风险显著增加。
  • 8年AV干预率单纯CABG为25.9%,CABG+SAVR为2.4%。

核心结论

  • 中度AS患者行CABG时推迟SAVR可能降低手术风险且不影响中期死亡率,但增加心衰再入院和后期AV干预。

研究设计与样本

  • 回顾性队列研究,利用STS成人心脏外科数据库2011至2022年数据,纳入65岁及以上中度AS行CABG或CABG+SAVR患者,排除心源性休克、心内膜炎、重度主动脉瓣反流和非胸骨正中切口病例,共18247例。

主要发现

  • 9325例(51.1%)行CABG+SAVR,8922例(48.9%)行单纯CABG。
  • 单纯CABG组手术死亡率和术后并发症更低。
  • 风险调整后中期全因死亡率相似。
  • 单纯CABG组中期心衰再入院和AV干预风险增加。
  • 8年AV干预率单纯CABG为25.9%,CABG+SAVR为2.4%。

临床怎么用

  • 对于中度AS行CABG的患者,可个体化考虑推迟SAVR以降低围手术期风险,但需告知患者心衰再入院和后期AV干预风险增加。

局限性

  • 原文未明确报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Established guidelines recommend consideration of concomitant surgical aortic valve replacement (SAVR) at the time of coronary artery bypass grafting (CABG) in patients with moderate aortic stenosis (AS) to avoid future reoperation for AS progression. The advent of transcatheter aortic valve replacement allows treatment of AS without mediastinal entry. This questions the optimal treatment choice of moderate AS in patients undergoing CABG. We compared outcomes of CABG with or without SAVR in patients with moderate AS. METHODS: Patients ≥65 years old with moderate AS who underwent CABG or CABG+SAVR from 2011 to 2022 were identified from The Society of Thoracic Surgeons Adult Cardiac Surgery Database. Exclusions included cardiogenic shock, endocarditis, severe aortic insufficiency, and non-sternotomy cases. Analyzed outcomes included perioperative complications, midterm mortality, and readmission for heart failure or aortic valve (AV) intervention. RESULTS: Of 18,247 patients, 9325 (51.1%) underwent CABG+SAVR and 8922 (48.9%) underwent isolated CABG. The isolated CABG cohort had lower operative mortality and postoperative complications. Risk-adjusted midterm outcomes showed similar all-cause mortality. Patients who underwent isolated CABG were at an increased risk for midterm readmission for heart failure and AV intervention. Rate of AV intervention at 8 years for isolated CABG patients compared with CABG+SAVR was 25.9% vs 2.4%, respectively. CONCLUSIONS: Deferring SAVR during CABG in patients with moderate AS may lower operative risk without affecting midterm mortality but increases heart failure readmissions and later AV interventions. Further studies are needed to determine whether delaying the AV intervention translates to reduced prosthetic valve degeneration without increasing long-term morbidity and mortality.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Yu PJ, Newman J, Chang SC, et al. Optimal Management for Moderate Aortic Stenosis at Time of Coronary Artery Bypass Grafting. Ann Thorac Surg. 2026. PMID: 42134562. doi:10.1016/j.athoracsur.2026.04.051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。